全球基因检测市场规模、份额、趋势和成长分析报告（2026-2034）

基因检测市场预计将从 2025 年的 48.1 亿美元成长到 2034 年的 211 亿美元，2026 年至 2034 年的复合年增长率为 17.86%。

受精准医疗和标靶治疗快速发展的推动，全球基因检测市场正经历加速成长。基因检测能够同时分析与特定疾病相关的多个基因，尤其适用于肿瘤学、心臟病学和罕见遗传疾病领域。全球癌症发生率的不断攀升显着推动了对全面肿瘤基因分析的需求。医疗机构正积极采用基因检测来提高诊断准确性和治疗方案的个人化。次世代定序（NGS）平台的技术进步正在提升侦测速度、扩充性和成本效益。

人们对遗传疾病和预防性基因筛检的认识不断提高，进一步推动了市场成长。医院和专业诊断实验室正在扩展其分子检测能力，以满足日益增长的患者需求。製药公司正在扩大基因组检测在临床试验中的应用，以识别适合标靶治疗的患者群体。生物技术公司与研究机构之间日益密切的合作正在加速创新。此外，已开发国家支持性的报销政策也促进了基因检测服务的广泛应用。

此外，生物资讯学和数据分析技术的进步，提高了对复杂基因组数据的解读能力，也对市场产生了正面影响。基于云端的基因组资料库实现了安全的数据共用和大规模研究计划。定序技术成本的降低使得基因panel检测在新兴市场更加普及。人工智慧在基因组分析中日益广泛的应用有望提升预测能力。伴随诊断的监管核准也进一步刺激了市场需求。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球基因检测市场：依产品与服务划分

• 市场分析、洞察与预测
• 检测套组
• 检查服务

第五章：全球基因检测市场：依方法论划分

• 市场分析、洞察与预测
• 基于放大器的方法
• 基于杂合反应的方法

第六章 全球基因检测市场：依设计划分

• 市场分析、洞察与预测
• 预先设计的基因面板
• 客製化基因面板

第七章 全球基因检测市场：依最终用途划分

• 市场分析、洞察与预测
• 学术研究机构
• 医院/诊断检查室
• 製药和生物技术公司

第八章 全球基因检测市场：依应用划分

• 市场分析、洞察与预测
• 癌症风险评估
• 先天性疾病的诊断
• 药物基因学
• 其他用途

第九章 全球基因检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Agilent Technologies
  • Illumina Inc
  • Qiagen Inc
  • Eurofins Genomics
  • Thermo Fisher Scientific
  • Foundation Medicine Inc
  • Guardant Health Inc
  • Myriad Genetic Laboratories Inc
  • Cepheid
  • Bio-Rad Laboratories Inc
  • Personalis

The Gene Panel Market size is expected to reach USD 21.10 Billion in 2034 from USD 4.81 Billion (2025) growing at a CAGR of 17.86% during 2026-2034.

The Global Gene Panel Market is experiencing accelerated growth driven by the rapid expansion of precision medicine and targeted therapies. Gene panels allow simultaneous analysis of multiple genes associated with specific diseases, particularly in oncology, cardiology, and rare genetic disorders. Increasing cancer prevalence worldwide has significantly boosted demand for comprehensive tumor profiling. Healthcare providers are adopting gene panels to improve diagnostic accuracy and treatment customization. Technological advancements in next-generation sequencing (NGS) platforms are enhancing speed, scalability, and cost-efficiency.

Rising awareness about inherited disorders and preventive genetic screening is further strengthening market growth. Hospitals and specialized diagnostic laboratories are expanding molecular testing capabilities to meet growing patient demand. Pharmaceutical companies are increasingly using gene panels in clinical trials to identify suitable patient populations for targeted drugs. Expanding collaborations between biotech firms and research institutes are accelerating innovation. Additionally, supportive reimbursement policies in developed economies are encouraging broader adoption of genetic testing services.

The market is also benefiting from advancements in bioinformatics and data analytics, which improve interpretation of complex genomic data. Cloud-based genomic databases enable secure data sharing and large-scale research initiatives. The decreasing cost of sequencing technologies is making gene panel testing more accessible in emerging markets. Growing integration of artificial intelligence in genomic analysis is expected to enhance predictive capabilities. Regulatory approvals for companion diagnostics are further driving demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Services

• Test Kits
• Testing Services

By Technique

• Amplicon Based Approach
• Hybridization Based Approach

By Design

• Predesigned Gene Panel
• Customized Gene Panel

By End Use

• Academic & Research Institutes
• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies

By Application

• Cancer Risk Assessment
• Diagnosis of Congenital Diseases
• Pharmacogenetics
• Other Applications

COMPANIES PROFILED

• Agilent Technologies, Illumina Inc, Qiagen Inc, Eurofins Genomics, Thermo Fisher Scientific, Foundation Medicine Inc, Guardant Health Inc, Myriad Genetic Laboratories Inc, Cepheid, BioRad Laboratories Inc, Personalis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENE PANEL MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENE PANEL MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique
• 5.2. Amplicon Based Approach Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hybridization Based Approach Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENE PANEL MARKET: BY DESIGN 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Design
• 6.2. Predesigned Gene Panel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Customized Gene Panel Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENE PANEL MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospital & Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENE PANEL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Cancer Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Diagnosis of Congenital Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Pharmacogenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENE PANEL MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Services
  • 9.2.2 By Technique
  • 9.2.3 By Design
  • 9.2.4 By End Use
  • 9.2.5 By Application
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Services
  • 9.3.2 By Technique
  • 9.3.3 By Design
  • 9.3.4 By End Use
  • 9.3.5 By Application
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Services
  • 9.4.2 By Technique
  • 9.4.3 By Design
  • 9.4.4 By End Use
  • 9.4.5 By Application
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Services
  • 9.5.2 By Technique
  • 9.5.3 By Design
  • 9.5.4 By End Use
  • 9.5.5 By Application
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Services
  • 9.6.2 By Technique
  • 9.6.3 By Design
  • 9.6.4 By End Use
  • 9.6.5 By Application
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL GENE PANEL INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies
  • 11.2.2 Illumina Inc
  • 11.2.3 Qiagen Inc
  • 11.2.4 Eurofins Genomics
  • 11.2.5 Thermo Fisher Scientific
  • 11.2.6 Foundation Medicine Inc
  • 11.2.7 Guardant Health Inc
  • 11.2.8 Myriad Genetic Laboratories Inc
  • 11.2.9 Cepheid
  • 11.2.10 Bio-Rad Laboratories Inc
  • 11.2.11 Personalis